| Name |
|---|
ASRT8 GeneAsthma-related traits, susceptibility to, 8 |
ASOBS GeneAsthma and obesity susceptibility, chromosome 16p11 inversion related |
ASRT6 GeneAsthma-related traits, susceptibility to, 6 |
ASRT4 GeneAsthma-related traits, susceptibility to, 4 |
ASRT3 GeneAsthma-related traits, susceptibility to, 3 |
AASTH40 GeneAllergic/atopic asthma related QTL 40 |
AASTH45 GeneAllergic/atopic asthma related QTL 45 |
AASTH18 GeneAllergic/atopic asthma related QTL 18 |
AASTH13 GeneAllergic/atopic asthma related QTL 13 |
AASTH15 GeneAllergic/atopic asthma related QTL 15 |
AASTH14 GeneAllergic/atopic asthma related QTL 14 |
AASTH16 GeneAllergic/atopic asthma related QTL 16 |
AASTH38 GeneAllergic/atopic asthma related QTL 38 |
AASTH37 GeneAllergic/atopic asthma related QTL 37 |
AASTH48 GeneAllergic/atopic asthma related QTL 48 |
AASTH49 GeneAllergic/atopic asthma related QTL 49 |
AASTH42 GeneAllergic/atopic asthma related QTL 42 |
AASTH43 GeneAllergic/atopic asthma related QTL 43 |
AASTH47 GeneAllergic/atopic asthma related QTL 47 |
AASTH44 GeneAllergic/atopic asthma related QTL 44 |
AASTH9 GeneAllergic/atopic asthma related QTL 9 |
AASTH8 GeneAllergic/atopic asthma related QTL 8 |
AASTH7 GeneAllergic/atopic asthma related QTL 7 |
AASTH6 GeneAllergic/atopic asthma related QTL 6 |
AASTH1 GeneAllergic/atopic asthma related QTL 1 |
AASTH3 GeneAllergic/atopic asthma related QTL 3 |
AASTH2 GeneAllergic/atopic asthma related QTL 2 |
AASTH29 GeneAllergic/Atopic asthma related QTL 29 |
AASTH24 GeneAllergic/atopic asthma related QTL 24 |
AASTH26 GeneAllergic/atopic asthma related QTL 25 |
AASTH27 GeneAllergic/atopic asthma related QTL 27 |
AASTH20 GeneAllergic/atopic asthma related QTL 20 |
AASTH21 GeneAllergic/atopic asthma related QTL 21 |
AASTH22 GeneAllergic/atopic asthma related QTL 22 |
AASTH41 GeneAllergic/Atopic asthma related QTL 41 |
AASTH46 GeneAllergic/atopic asthma related QTL 46 |
AASTH25 GeneAllergic/atopic asthma related QTL 25 |
AASTH55 GeneAllergic/atopic asthma related QTL 5 |
AASTH54 GeneAllergic/atopic asthma related QTL 54 |
AASTH56 GeneAllergic/Atopic asthma related QTL 56 |
AASTH51 GeneAllergic/atopic asthma related QTL 51 |
AASTH53 GeneAllergic/atopic asthma related QTL 53 |
AASTH52 GeneAllergic/atopic asthma related QTL 52 |
AASTH4 GeneAllergic/atopic asthma related QTL 4 |
AASTH11 GeneAllergic/atopic asthma related QTL 11 |
AASTH12 GeneAllergic/atopic asthma related QTL 12 |
AASTH17 GeneAllergic/atopic asthma related QTL 17 |
AASTH19 GeneAllergic/atopic asthma related QTL 19 |
AASTH10 GeneAllergic/atopic asthma related QTL 10 |
AASTH50 GeneAllergic/atopic asthma related QTL 50 |
AASTH39 GeneAllergic/atopic asthma related QTL 39 |
AASTH36 GeneAllergic/atopic asthma related QTL 36 |
AASTH35 GeneAllergic/atopic asthma related QTL 35 |
AASTH34 GeneAllergic/atopic asthma related QTL 34 |
AASTH33 GeneAllergic/atopic asthma related QTL 33 |
AASTH32 GeneAllergic/Atopic asthma related QTL 32 |
AASTH31 GeneAllergic/atopic asthma related QTL 31 |
AASTH30 GeneAllergic/atopic asthma related QTL 30 |
AASTH5 GeneAllergic/atopic asthma related QTL 5 |
AASTH28 GeneAllergic/Atopic asthma related QTL 28 |
AASTH23 GeneAllergic/atopic asthma related QTL 23 |
BMIQ7 GeneObesity, susceptibility to, on chromosome 4 |
ASPG2 GeneAsperger syndrome, susceptibility to, 2 |
ASPG3 GeneAsperger syndrome, susceptibility to, 3 |
ASPG4 GeneAsperger syndrome, susceptibility to, 4 |
ATOD7 GeneDermatitis, atopic, susceptibility to, 7 |
ENDO1 GeneEndometriosis, susceptibility to, 1 |
HYT3 GeneHypertension, essential, susceptibility to, 3 |
HYT5 GeneHypertension, essential, susceptibility to, 5 |
HYT4 GeneHypertension, essential, susceptibility to, 4 |
HYT7 GeneHypertension, essential, susceptibility to, 7 |
HYT6 GeneHypertension, essential, susceptibility to, 6 |
HYT8 Genehypertension, essential, susceptibility to, 8 |
MGR7 GeneMigraine with aura, susceptibility to, 7 |
MGR9 GeneMigraine with aura, susceptibility to, 9 |
GRD2 GeneGraves disease, susceptibility to, 2 |
GRDX GeneGraves disease, susceptibility to, X-linked |
EIG4 GeneEpilepsy, idiopathic generalized, susceptibility to 4 |
PRAC2 Geneprostate cancer susceptibility candidate 2 This gene is highly expressed in prostate, rectum, colon, and testis. This gene may produce a non-coding RNA or may encode a short protein that might localize to the nucleus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013] |
PRAC1 Geneprostate cancer susceptibility candidate 1 This gene is reported to be specifically expressed in prostate, rectum and distal colon. Sequence analysis suggests that it may play a regulatory role in the nucleus. [provided by RefSeq, Jul 2008] |
SS3 GeneSarcoidosis, susceptibility to, 3 |
BMIQ10 GeneObesity, susceptibility to, on chromosome 10q |
PSORS9 Genepsoriasis susceptibility 9 |
PSORS8 Genepsoriasis susceptibility 8 |
PSORS7 Genepsoriasis susceptibility 7 |
PSORS6 Genepsoriasis susceptibility 6 |
PSORS5 Genepsoriasis susceptibility 5 |
PSORS4 Genepsoriasis susceptibility 4 |
PSORS3 Genepsoriasis susceptibility 3 |
NKS1 Genenatural killer cell susceptibility 1 |
CELIAC8 GeneCeliac disease, susceptibility to, 8 |
CELIAC5 GeneCeliac disease, susceptibility to, 5 |
CELIAC6 GeneCeliac disease, susceptibility to, 6 |
CELIAC7 GeneCeliac disease, susceptibility to, 7 |
AIS3 Geneautoimmune susceptibility 3 (vitiligo specific) |
AIS2 Geneautoimmune susceptibility 2 |
AIS1 Geneautoimmune susceptibility 1 |
AIS4 Geneautoimmune disease, susceptibility to, 4 |
SLEB13 GeneSystemic lupus erythematosus, susceptibility to, 13 |
SLEB12 GeneSystemic lupus erythematosus, susceptibility to, 12 |
SLEB15 GeneSystemic lupus erthematosus, susceptibility to, 15 |
CIHL Genehearing loss, cisplatin-induced, susceptibility to |
IGAD1 Geneimmunoglobulin A (IgA) deficiency susceptibility 1 |
OS4 GeneOsteoarthritis, generalized, without dysplasia, susceptibility to |
OS6 GeneOsteoarthritis susceptibility 6 |
CASC4P1 Genecancer susceptibility candidate 4 pseudogene 1 |
BCC5 GeneBasal cell carcinoma, susceptibility to, 5 |
NBLST5 GeneNeuroblastoma, susceptibility to, 5 |
NBLST4 GeneNeuroblastoma, susceptibility to, 4 |
NBLST6 GeneNeuroblastoma, susceptibility to, 6 |
MAFD9 GeneMajor affective disorder-9, susceptibility to |
MAFD8 GeneMajor affective disorder-8, susceptibility to |
IGAN2 GeneIgA nephropathy, susceptibility to, 2 |
AUTS6 GeneAutism, susceptibility to, 6 |
AUTS7 GeneAutism, susceptibility to, 7 |
AUTS5 GeneAutism, susceptibility to, 5 |
AUTS2 Geneautism susceptibility candidate 2 This gene has been implicated in neurodevelopment and as a candidate gene for numerous neurological disorders, including autism spectrum disorders, intellectual disability, and developmental delay. Mutations in this gene have also been associated with non-neurological disorders, such as acute lymphoblastic leukemia, aging of the skin, early-onset androgenetic alopecia, and certain cancers. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2014] |
AUTS3 GeneAutism, susceptibility to, 3 |
AUTS1 GeneAutism, susceptibility to, 1 |
AUTS8 GeneAutism, susceptibility to, 8 |
EIG3 GeneEpilepsy, idiopathic generalized, susceptibility to 3 |
EIG2 GeneEpilepsy, idiopathic generalized, susceptibility to 2 |
CASC2 Genecancer susceptibility candidate 2 (non-protein coding) Involved in defense response to tumor cell; negative regulation of MAPK cascade; and positive regulation of cysteine-type endopeptidase activity. [provided by Alliance of Genome Resources, Mar 2025] |
CASC1 Genecancer susceptibility candidate 1 Predicted to enable beta-tubulin binding activity and microtubule binding activity. Predicted to be located in cilium and microtubule cytoskeleton. Predicted to be part of axonemal dynein complex. Predicted to be active in axoneme and cytoplasmic microtubule. [provided by Alliance of Genome Resources, Mar 2025] |
CASC6 Genecancer susceptibility candidate 6 (non-protein coding) |
CASC5 Genecancer susceptibility candidate 5 The protein encoded by this gene is a component of the multiprotein assembly that is required for creation of kinetochore-microtubule attachments and chromosome segregation. The encoded protein functions as a scaffold for proteins that influence the spindle assembly checkpoint during the eukaryotic cell cycle and it interacts with at least five different kinetochore proteins and two checkpoint kinases. In adults, this gene is predominantly expressed in normal testes, various cancer cell lines and primary tumors from other tissues and is ubiquitously expressed in fetal tissues. This gene was originally identified as a fusion partner with the mixed-lineage leukemia (MLL) gene in t(11;15)(q23;q14). Mutations in this gene cause autosomal recessive primary microcephaly-4 (MCPH4). Alternative splicing results in multiple transcript variants encoding different isoforms. Additional splice variants have been described but their biological validity has not been confirmed. [provided by RefSeq, Jan 2013] |
CASC4 Genecancer susceptibility candidate 4 The increased expression level of this gene is associated with HER-2/neu proto-oncogene overexpression. Amplification and resulting overexpression of this proto-oncogene are found in approximately 30% of human breast and 20% of human ovarian cancers. Alternatively spliced variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Dec 2010] |
CASC8 Genecancer susceptibility candidate 8 (non-protein coding) |
HYT1 GeneHypertension, essential, susceptibility to, 1 |
HYT2 GeneHypertension, essential, susceptibility to, 2 |
BCC6 GeneBasal cell carcinoma, susceptibility to, 6 |
CASC18 Genecancer susceptibility candidate 18 (non-protein coding) |
ADHD2 GeneAttention deficit-hyperactivity disorder, susceptibility to, 2 |
CLLS1 GeneLeukemia, chronic lymphocytic, susceptibility to, 1 |
LOC101930332 Geneautism susceptibility gene 2 protein-like |
OVCAS1 GeneOvarian cancer, epithelial, susceptibility to |
OMS Geneotitis media, susceptibility to |
EIG5 GeneEpilepsy, idiopathic generalized, susceptibility to, 5 |
KAZA1 GeneKala-azar (visceral leishmaniasis), susceptibility to |
KAZA2 GeneKala-azar, susceptibility to, 2 |
KAZA3 GeneKala-azar, susceptibility to, 3 |
DYX5 Genedyslexia susceptibility 5 |
PSORS1C1 Genepsoriasis susceptibility 1 candidate 1 This gene is one of several genes thought to confer susceptibility to psoriasis and systemic sclerosis, located on chromosome 6 near the major histocompatibility complex (MHC) class I region. [provided by RefSeq, Sep 2011] |
PSORS1C3 Genepsoriasis susceptibility 1 candidate 3 (non-protein coding) |
PSORS1C2 Genepsoriasis susceptibility 1 candidate 2 Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Mar 2025] |
AUTS11 GeneAutism, susceptibility to, 11 |
AUTS12 Geneautism, susceptibility to, 12 |
AUTS13 Geneautism, susceptibility to, 13 |
HPC6 GeneProstate cancer, susceptibility to |
MTBS3 GeneMycobacterium tuberculosis, susceptibility to, 3 |
MTBS2 GeneMycobacterium tuberculosis, susceptibility to, 2 |
MTBS1 Genemycobacterium tuberculosis, susceptibility to infection by, 1 |
MTBSX GeneMycobacterium tuberculosis, susceptibility to infection by |
CASC3 Genecancer susceptibility candidate 3 The product of this gene is a core component of the exon junction complex (EJC), a protein complex that is deposited on spliced mRNAs at exon-exon junctions and functions in nonsense-mediated mRNA decay (NMD). The encoded protein binds RNA and interacts with two other EJC core components. It is predominantly located in the cytoplasm, but shuttles into the nucleus where it localizes to nuclear speckles. [provided by RefSeq, Jul 2008] |
CASC7 Genecancer susceptibility candidate 7 (non-protein coding) |
CASC9 Genecancer susceptibility candidate 9 (non-protein coding) |
CHDS4 GeneCoronary heart disease, susceptibility to, 4 |
CLLS3 GeneLeukemia, chronic lymphocytic, susceptibility to, 3 |
CASC11 Genecancer susceptibility candidate 11 (non-protein coding) Enables chromatin-protein adaptor activity and promoter-enhancer loop anchoring activity. Involved in chromatin looping and positive regulation of transcription by RNA polymerase II. Is active in nucleus. [provided by Alliance of Genome Resources, Mar 2025] |
CASC10 Genecancer susceptibility candidate 10 |
CASC17 Genecancer susceptibility candidate 17 (non-protein coding) |
CASC16 Genecancer susceptibility candidate 16 (non-protein coding) |
CASC15 Genecancer susceptibility candidate 15 (non-protein coding) This gene produces a long non-coding RNA that may regulate cell proliferation. This RNA is upregulated in hepatocellular carcinoma, where it is thought to function as an oncogene. However, some splice variants of this gene may function as a tumor suppressor in neuroblastoma and other tumor types. Circular RNA variants were observed at this gene. [provided by RefSeq, Dec 2017] |
CASC19 Genecancer susceptibility candidate 19 (non-protein coding) |
ADHD4 GeneAttention deficit-hyperactivity disorder, susceptibility to, 4 |
ADHD5 GeneAttention deficit-hyperactivity disorder, susceptibility to, 5 |
ADHD6 GeneAttention deficit-hyperactivity disorder, susceptibility to, 6 |
ADHD1 GeneAttention deficit-hyperactivity disorder, susceptibility to, 1 |
ADHD3 GeneAttention deficit-hyperactivity disorder, susceptibility to, 2 |
BULN GeneBulimia nervosa, susceptibility to |
ALL2 GeneLeukemia, acute lymphoblastic, susceptibility to, 2 |
GLM6 GeneGlioma susceptibility 6 |
GLM7 GeneGlioma susceptibility 7 |
GLM5 GeneGlioma susceptibility 5 |
GLM8 GeneGlioma susceptibility 8 |
STBMS1 GeneStrabismus, susceptibility to, 1 |
IS5 Genescoliosis, idiopathic, susceptibility to, 5 |
IS4 GeneScoliosis, idiopathic, susceptibility to, 4 |
CRCS10 GeneColorectal cancer, susceptibility to, 10 |
CRCS11 GeneColorectal cancer, susceptibility to, 11 |
NPCA2 GeneNasopharyngeal carcinoma, susceptibility to, 2 |
SM2 GeneHepatic fibrosis susceptibility due to Schistosoma mansoni infection |
SM1 GeneSchistosoma mansoni, susceptibility/resistance to |
PDCOS GenePodoconiosis, susceptibility to |
CTEPH1 GenePulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to |
DEL16P11.2 Geneautism, susceptibility to, 14 |
BTS1 Genebladder tumor susceptibility 1 |
PTCSC1 Genepapillary thyroid carcinoma susceptibility candidate 1 (non-protein coding) |
PTCSC3 Genepapillary thyroid carcinoma susceptibility candidate 3 (non-protein coding) |
CASC23 Genecancer susceptibility candidate 23 (non-protein coding) |
CASC22 Genecancer susceptibility candidate 22 (non-protein coding) |
CASC20 Genecancer susceptibility candidate 20 (non-protein coding) |
CASC21 Genecancer susceptibility candidate 21 (non-protein coding) |
CRCS8 GeneColorectal cancer, susceptibility to, 8 |
CRCS9 Genecolorectal cancer, susceptibility to, 9 |
CRCS2 GeneColorectal cancer, susceptibility to, 2 |
CRCS5 GeneColorectal cancer, susceptibility to, 5 |
MBNP Gene?Membranous nephropathy, susceptibility to |
NAFLD2 GeneFatty liver disease, nonalcoholic, susceptibility to, 2 |
ANON1 GeneAnorexia nervosa, susceptibility to, 1 |
BCC4 GeneBasal cell carcinoma, susceptibility to, 4 |
CMM7 GeneMelanoma, cutaneous malignant, susceptibility to, 7 |
LNCR3 GeneLung cancer susceptibility 3 |
LNCR4 GeneLung cancer susceptibility 4 |
LNCR5 GeneLung cancer susceptibility 5 |
CLLS4 GeneLeukemia, chronic lymphocytic susceptibility to, 4 |
AITD2 GeneAutoimmune thyroid disease, susceptibility to, 2 |
AITD1 GeneAutoimmune thyroid disease, susceptibility to, 1 |
AITD4 GeneAutoimmune thyroid disease, susceptibility to, 4 |
MS3 GeneMultiple sclerosis, susceptibility to, 3 |
MS2 GeneMultiple sclerosis, susceptibility to, 2 |
DYX9 Genedyslexia susceptibility 9 |
DYX8 Genedyslexia susceptibility 8 |
MHS6 Genemalignant hyperthermia susceptibility 6 |
MHS4 Genemalignant hyperthermia susceptibility 4 |
MHS2 Genemalignant hyperthermia susceptibility 2 |
MHS3 GeneMalignant hyperthermia susceptibility 3 |
MGR2 GeneMigraine, familial typical, susceptibility to |
MGR3 GeneMigraine, familial, with or without aura, susceptibility to |
MGR1 GeneMigraine with aura, susceptibility to |
MGR5 GeneMigraine with or without aura, susceptibility to, 5 |
MGR8 GeneMigraine, susceptibility to, 8 |
TSG101 Genetumor susceptibility 101 The protein encoded by this gene belongs to a group of apparently inactive homologs of ubiquitin-conjugating enzymes. The gene product contains a coiled-coil domain that interacts with stathmin, a cytosolic phosphoprotein implicated in tumorigenesis. The protein may play a role in cell growth and differentiation and act as a negative growth regulator. In vitro steady-state expression of this tumor susceptibility gene appears to be important for maintenance of genomic stability and cell cycle regulation. Mutations and alternative splicing in this gene occur in high frequency in breast cancer and suggest that defects occur during breast cancer tumorigenesis and/or progression. [provided by RefSeq, Jul 2008] |
HDPA GeneHodgkin disease, susceptibility, pseudoautosomal |
ASPG1 GeneAsperger syndrome, susceptibility to, 1 |
SCZD14 Geneschizophrenia, susceptibility to, 14 |
SCZD11 GeneSchizophrenia susceptibility locus, chromosome 10q-related |
LOC100288160 Geneesophagus cancer-related gene-2 interaction susceptibility protein |
BCC1 GeneBasal cell carcinoma, susceptibility to, 1 |
BCC2 GeneBasal cell carcinoma, susceptibility to, 2 |
BCC3 GeneBasal cell carcinoma, susceptibility to, 3 |
ODS1 GeneOpioid dependence, susceptibility to, 1 |
PARK16 GeneParkinson disease 16 (susceptibility) |
PARK10 GeneParkinson disease 10 (susceptibility) |
PARK12 GeneParkinson disease 12 (susceptibility) |
PDA1 GenePatent ductus arteriosus, susceptibility to |
LPRS GeneLeprosy, susceptibility to 1 |
CRCS6 Genecolorectal cancer, susceptibility to, 6 |
MMS GeneMalignant mesothelioma, susceptibility to |
DYX1C1 Genedyslexia susceptibility 1 candidate 1 This gene encodes a tetratricopeptide repeat domain-containing protein. The encoded protein interacts with estrogen receptors and the heat shock proteins, Hsp70 and Hsp90. An homologous protein in rat has been shown to function in neuronal migration in the developing neocortex. A chromosomal translocation involving this gene is associated with a susceptibility to developmental dyslexia. Mutations in this gene are associated with deficits in reading and spelling. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the downstream cell cycle progression 1 (CCPG1) gene. [provided by RefSeq, Mar 2011] |
MGR4 GeneMigraine, susceptibility to, 4 |
HSCR9 GeneHirschsprung disease, susceptibility to, 9 |
HSCR5 GeneHirschsprung disease, susceptibility to, 5 The disorder described by Hirschsprung (1888) and known as Hirschsprung disease or aganglionic megacolon is characterized by congenital absence of intrinsic ganglion cells in the myenteric (Auerbach) and submucosal (Meissner) plexuses of the gastrointestinal tract. Patients are diagnosed with the short-segment form (S-HSCR, approximately 80% of cases) when the aganglionic segment does not extend beyond the upper sigmoid, and with the long-segment form (L-HSCR) when aganglionosis extends proximal to the sigmoid. Total colonic aganglionosis and total intestinal HSCR also occur (Amiel et al., 2008 [PubMed 17965226]). Isolated HSCR appears to be of complex nonmendelian inheritance with low sex-dependent penetrance and variable expression according to the length of the aganglionic segment, suggestive of the involvement of one or more genes with low penetrance (Amiel et al., 2008 [PubMed 17965226]). For a general description and a discussion of genetic heterogeneity of Hirschsprung disease (HSCR), see MIM 142623.[supplied by OMIM, Feb 2011] |
PTCSC2 Genepapillary thyroid carcinoma susceptibility candidate 2 (non-protein coding) |
DYX1 Genedyslexia susceptibility 1 |
DYX3 Genedyslexia susceptibility 3 |
DYX4 Genedyslexia susceptibility 4 |
DYX7 Genedyslexia susceptibility 7 |
DYX6 Genedyslexia susceptibility 6 |
FL1 GeneFollicular lymphoma, susceptibility to, 1 |
TGCT1 Genetesticular germ cell tumor susceptibility 1 |
DELXP22.11 GeneAutism, X-linked, susceptibility to, 4 |
RLS1 GeneRestless legs syndrome, susceptibility to |
RLS6 GeneRestless legs syndrome, susceptibility to, 6 |
RLS5 GeneRestless legs syndrome, susceptibility to, 5 |
RLS8 GeneRestless legs syndrome, susceptibility to, 8 |
CELIAC9 GeneCeliac disease, susceptibility to, 9 |
ALL1 GeneLeukemia, acute lymphocytic, susceptibility to, 1 |
LOAS GeneLeber optic atrophy, susceptibility to |
SLEB4 Genesystemic lupus erythematosus, susceptibility to, 4 |
UVM2 GeneMelanoma, uveal, susceptibility to, 2 |
UVM1 GeneMelanoma, uveal, susceptibility to, 1 |
ARMS2 Geneage-related maculopathy susceptibility 2 This gene encodes a small secreted protein specific to primates. This protein is a component of the choroidal extracellular matrix of the eye. Mutations in this gene are associated with age-related macular degeneration. [provided by RefSeq, Sep 2017] |
ATHS Geneatherosclerosis susceptibility (lipoprotein associated) |
WM2 GeneMacroglobulinemia, Waldenstrom, susceptibility to, 2 |
CMTS GeneChronic mountain sickness, susceptibility to |
CHDS3 GeneCoronary heart disease, susceptibility to, 3 |
CHDS2 GeneCoronary heart disease, susceptibility to, 2 |
CHDS1 GeneCoronary heart disease, susceptibility to, 1 |
CHDS8 GeneCoronary heart disease, susceptibility to, 8 |
HHV8S GeneHuman herpesvirus 8, susceptibility to |
IDDMX GeneDiabetes mellitus, insulin-dependent, X-linked, susceptibility to |
SLEB5 GeneSystemic lupus erythematosus, susceptibility to, 5 |
SLEB8 GeneSystemic lupus erythematosus, susceptibility to, 8 |
PSORS11 GenePsoriasis susceptibility 11 |
PSORS10 Genepsoriasis susceptibility 10 |
SPDA3 GeneSpondylarthropathy, susceptibility to, 3 |
SPDA2 GeneSpondyloarthropathy, susceptibility to, 2 |
MGR12 GeneMigraine, with or without aura, susceptibility to, 12 |
WM1 GeneMacroglobulinemia, Waldenstrom, susceptibility to, 1 |
CRCS7 Genecolorectal cancer, susceptibility to, 7 |
CELIAC12 GeneCeliac disease, susceptibility to, 12 |
CELIAC13 GeneCeliac disease, susceptibility to, 13 |
CELIAC10 GeneCeliac disease, susceptibility to, 10 |
CELIAC11 GeneCeliac disease, susceptibility to, 11 |
PVOP1 GenePelvic organ prolapse, susceptibility to, 1 |
PVOP2 GenePelvic organ prolapse, susceptibility to, 2 |
SLEB3 Genesystemic lupus erythematosus susceptibility 3 |
SLEB7 GeneSystemic lupus erythematosus, susceptibility to, 7 |